Cargando…
Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy
BACKGROUND: Autoantibodies specific for the adrenergic beta1-receptor were identified to be an essential factor for the pathogenesis of dilated cardiomyopathy. For the detection of these autoantibodies, a bioassay was developed and has been used, measuring the positive chronotropic effect on spontan...
Autores principales: | Wenzel, Katrin, Schulze-Rothe, Sarah, Haberland, Annekathrin, Müller, Johannes, Wallukat, Gerd, Davideit, Hanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541141/ https://www.ncbi.nlm.nih.gov/pubmed/28795160 http://dx.doi.org/10.1016/j.heliyon.2017.e00362 |
Ejemplares similares
-
Difference between beta1-adrenoceptor autoantibodies of human and animal origin—Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology
por: Wenzel, Katrin, et al.
Publicado: (2018) -
Antigen-free control wells in an ELISA set-up for the determination of autoantibodies against G protein-coupled receptors—a requisite for correct data evaluation
por: Haberland, Annekathrin, et al.
Publicado: (2018) -
Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling—Additional Information About TLR9 Involvement
por: Haberland, Annekathrin, et al.
Publicado: (2019) -
A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects
por: Becker, Niels-Peter, et al.
Publicado: (2020) -
Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms
por: Wallukat, Gerd, et al.
Publicado: (2021)